TSO3 Ozone Sterilizer to be tested by British Government for ability to deactivate prions
The Health Protection Agency (HPA) has recently been awarded a grant of £327k (approximately $710k CAN) by the UK Department of Health (DH) to study the effectiveness of the TSO3 ozone Sterilizer for deactivation of prions.
"The potential transmission of CJD from patient to patient via contaminated surgical instruments has been a concern worldwide for a number of years", said Dr. Neil Raven, Research Manager of the HPA. "The data from the preliminary tests conducted by TSO3 lead us to believe that the Ozone Sterilizer could be a significant part of the solution to the problem of variant CJD (vCJD), the human form of mad cow disease. That is why we have been working for nearly a year and a half on developing a protocol with TSO3 and obtaining the funding from the DH".
"We are one of the rare foreign companies to benefit from a grant of this size. The interest Britain is showing to our technology both confirms the need for a sterilization method that will deactivate prions and ozone's potential for being one of the solutions," said Simon Robitaille, Vice President, Operations, and Director of Research at TSO3.
Other news from the department research and development
